Showing 7551-7560 of 20412 results for "".
Engaging Patients and Caregivers About Digital Therapeutics
https://reachmd.com/programs/medical-industry-feature/engaging-patients-caregivers-digital-therapeutics/39782/Guiding patients and caregivers through the fast-moving landscape of digital therapeutics can be a challenging but worthwhile part of providing effective and accessible care. That’s why Dr. Charles Turck speaks with Dr. Maggie Emerson about how we can best partner with patients and caregivers aroundUnderstanding CPET for Athletes: Protocols and Pitfalls
https://reachmd.com/programs/heart-matters/cpet-athletes-protocols-pitfalls/54809/Performing appropriate cardiopulmonary exercise testing (CPET) for athletes relies on a strong foundation in exercise physiology, structured protocols, and direct clinical oversight. Learn more as Dr. Benjamin Levine shares key considerations in test design, limitations of standard treadmill protocoFirst-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
https://reachmd.com/programs/clinicians-roundtable/first-in-human-trial-of-a-germline-targeting-hiv-env-trimer-vaccine/32855/Exploring Common Barriers in Pediatric Atopic Dermatitis Management
https://reachmd.com/programs/dermconsult/exploring-common-barriers-in-pediatric-atopic-dermatitis-management/36442/Even though there are a lot of treatment options available for pediatric atopic dermatitis, family concerns about safety and access play a big role in management. Tune in to hear Dr. Nicole Harter, Associate Professor in the Department of Dermatology and the Pediatric Dermatology Fellowship ProgramRefining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
https://reachmd.com/programs/project-oncology/refining-first-line-therapy-in-advanced-endometrial-care-leap-001-trial-results/35507/To explore a potential alternative to chemotherapy, the ENGOT-en9/LEAP-001 trial compared lenvatinib/pembrolizumab to standard chemotherapy in patients with advanced or recurrent endometrial cancer. Learn how these results may shape biomarker-driven approaches and patient selection in frontline endoProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
https://reachmd.com/programs/clinicians-roundtable/prostate-cancer-and-cannabis-use-exploring-results-from-a-case-control-study/35696/Preclinical findings in animal models have shown that activating cannibinoid receptors can shrink prostate tumors in animal models. To explore whether these effects translate to human populations, a recent study examined a potential link between cannabis use and the development of prostate cancer. HTreating ATTR-CM: Current Strategies and Emerging Options
https://reachmd.com/programs/heart-matters/treating-attr-cm-current-strategies-and-emerging-options/33059/Hear about FDA-approved agents and promising clinical trials that are advancing the therapeutic landscape for transthyretin amyloid cardiomyopathy.Optimizing the Screening of Precursor Diseases in Multiple Myeloma
https://reachmd.com/programs/project-oncology/optimizing-the-screening-of-precursor-diseases-in-multiple-myeloma/27008/Learn about our current approach to screening patients for precursor diseases in multiple myeloma and how we may be able to optimize it.The Network Effect: Analyzing Brain Structures to Treat Depression
https://reachmd.com/programs/medical-industry-feature/the-network-effect-analyzing-brain-structures-to-treat-depression/18095/Find out how analyzing expanded brain structures has led to revolutionary diagnoses and treatments.Oral Vitamin D Supplementation and Psoriasis Severity
https://reachmd.com/programs/practical-dermatology/oral-vitamin-d-supplementation-and-psoriasis-severity/24213/In the 2023 study by Jenssen et al. entitled, “Effect of Vitamin D Supplementation on Psoriasis Severity in Patients with Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial,” high-dose oral vitamin D supplementation was not found to have a significant effect on psoriasis sever